UA69875U - Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis - Google Patents

Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis

Info

Publication number
UA69875U
UA69875U UAU201115147U UAU201115147U UA69875U UA 69875 U UA69875 U UA 69875U UA U201115147 U UAU201115147 U UA U201115147U UA U201115147 U UAU201115147 U UA U201115147U UA 69875 U UA69875 U UA 69875U
Authority
UA
Ukraine
Prior art keywords
treatment
corvitin
setting
myocardial infarction
antioxidant efficacy
Prior art date
Application number
UAU201115147U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Лариса Владимировна Журавлева
Марина Вячеславовна Филоненко
Оксана Ивановна Цивенко
Наталья Николаевна Котовщикова
Ольга Викторовна Лахно
Original Assignee
Харьковский Национальный Медицинский Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковский Национальный Медицинский Университет filed Critical Харьковский Национальный Медицинский Университет
Priority to UAU201115147U priority Critical patent/UA69875U/en
Publication of UA69875U publication Critical patent/UA69875U/en

Links

Abstract

A method for assessing the antioxidant efficacy of Corvitin in the treatment of the acute myocardial infarction in the setting of non-alcoholic steatohepatitis comprises the comparison of blood parameters prior to and after then treatment. Prior to the treatment, the sample of 5 mL of venous blood is taken at rest. The content of alpha-tocopherol and retinol is measured using chromatography technique at 295 nm for alpha-tocopherol and 330 nm for retinol. The repeated measurements are provided after the treatment. When the content of both vitamins increased at least by 10 %, the antioxidant efficacy is considered as positive one.
UAU201115147U 2011-12-21 2011-12-21 Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis UA69875U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201115147U UA69875U (en) 2011-12-21 2011-12-21 Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201115147U UA69875U (en) 2011-12-21 2011-12-21 Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis

Publications (1)

Publication Number Publication Date
UA69875U true UA69875U (en) 2012-05-10

Family

ID=52297285

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201115147U UA69875U (en) 2011-12-21 2011-12-21 Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis

Country Status (1)

Country Link
UA (1) UA69875U (en)

Similar Documents

Publication Publication Date Title
AU2018260825A1 (en) Compositions and Methods for Lowering Levels of High-Sensitivity (hs-CRP) in a Subject
WO2014004993A3 (en) Methods of reducing ldl-p
WO2013006490A3 (en) Antibodies that specifically bind to tim3
MX2020008031A (en) Compositions and methods for reducing blood alcohol content.
MX338515B (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors.
AU2008313418A8 (en) Composition for regulating lipid metabolism
MY165499A (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
UA105487C2 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
MX2013014708A (en) Glioblastoma inhibiting compounds and their use.
MX2013011833A (en) Infant formula for use in the prevention of cardiovascular diseases.
MX2015015036A (en) Methods for improving lipid profiles using atrasentan.
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
WO2012145399A3 (en) Methods of diagnosing cancer in a patient
MX2012010520A (en) Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs.
WO2014049438A3 (en) Method of non-invasive determination of glucose concentration in blood and device for the implementation thereof
MY160869A (en) Synergistic antioxidant composition
UA69875U (en) Method for assessing antioxidant efficacy of corvitin in treatment of acute myocardial infarction in setting of non-alcoholic steatohepatitis
WO2014059326A3 (en) Methods of identifying compounds for treating depression and other related diseases
EA201491455A1 (en) EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE
苗雄鹰 Expression of ABCG2, SFRP2, BRMS1 and HPA in benign and malignant lesions of the gallbladder and their clinicopathological significances
UA106112C2 (en) Process of ethanol dehydration
UA61835U (en) Method for determination of degree of affection of lipid metabolism in patients with ischemic heart disease
UA56466U (en) METHOD FOR EVALUATION OF effectiveness of treatment of patients with essential hypertension combined with osteorathrosis
UA73760U (en) Method for the prediction of cardio-vascular complications in patients of advanced and old ages with coronary heart disease
UA68903U (en) Method for evaluation of efficiency of treatment of hypothyroid encephalopathy